Latest News for: pah

Edit

Christmas events at PAHS benefit animals

Tri-County Tribune 23 Dec 2025
Login. Sign up for complimentary access ... Close ....
Edit

From Revolutionary War Graves to Modern Conflicts: Picatinny Arsenal and PAHS Expand Wreaths Across America Tributes (The United States Army)

Public Technologies 13 Dec 2025
Army Garrison Picatinny Arsenal officials, along with the assistance of the Picatinny Arsenal Historical Society (PAHS), conducted a wreath laying ceremony in coordination with the ...
Edit

Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)

Pharmiweb 12 Dec 2025
The most common PAH etiologies were idiopathic PAH (50%), PAH associated with connective tissue diseases (CTD) (28%), and heritable PAH (11%).
Edit

Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)

PR Newswire 08 Dec 2025
Food and Drug Administration (FDA) has granted clearance to initiate the company's Phase IIb trial of its lead drug candidate CS1 for the treatment of pulmonary arterial hypertension (PAH) ... About PAH.
Edit

Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH) (Cereno Scientific AB)

Public Technologies 08 Dec 2025
Food and Drug Administration (FDA) has granted clearance to initiate the company's Phase IIb trial of its lead drug candidate CS1 for the treatment of pulmonary arterial hypertension (PAH) ... About PAH.
Edit

Polycyclic aromatic hydrocarbons (PAHs): challenges for the water environment (The Environment Agency)

Public Technologies 20 Nov 2025
). The text version of this document is not available ... Disclaimer ... (noodl. 127870470) .
Edit

Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA (Cereno Scientific AB)

Public Technologies 10 Nov 2025
The submission marks an important milestone, moving the company closer to advancing CS1 into its next clinical phase and toward bringing a novel therapeutic approach to patients living with pulmonary arterial hypertension (PAH).
Edit

Cereno Scientific Submits Phase IIb Trial Protocol for CS1 in Pulmonary Arterial Hypertension (PAH) to the U.S. FDA

PR Newswire 10 Nov 2025
The submission marks an important milestone, moving the company closer to advancing CS1 into its next clinical phase and toward bringing a novel therapeutic approach to patients living with pulmonary arterial hypertension (PAH).
Edit

MICE CAFE: A spectacular evening of music set to raise funds for PAH Museum

B & FT Online 02 Nov 2025
All proceeds go to support the Pan African Heritage Museum’s mission to build a world-class institution celebrating African culture and history. Contact 0591188663 to secure your spot. Post Views. 1 ... Subscribe ....
Edit

See Spot Run for PAHS 2025

Tri-County Tribune 16 Oct 2025
Photo Gallery pictures by Jennifer Stultz/Tri-County Tribune ....
×